跳转至内容
Merck

90221

Supelco

瑞替加滨

analytical standard

别名:

D-23129, N-(2-氨基-4-(4-氟苄基氨基)苯基)氨基甲酸乙酯, 依佐加滨

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C16H18FN3O2
分子量:
303.33
Beilstein:
8072099
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

等級

analytical standard

品質等級

化驗

≥98.0% (HPLC)

儲存期限

limited shelf life, expiry date on the label

藥物控制

USDEA Schedule IV

技術

HPLC: suitable
gas chromatography (GC): suitable

雜質

≤1.0% water (calc. from elemental analysis)

應用

forensics and toxicology
veterinary

格式

neat

儲存溫度

2-8°C

SMILES 字串

FC1=CC=C(CNC2=CC(N)=C(NC(OCC)=O)C=C2)C=C1

InChI

1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)

InChI 密鑰

PCOBBVZJEWWZFR-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

一般說明

瑞替加滨是一种抗癫痫药物,它通过诱导稳态激活的大型超极化转变(hyperpolarizing shift)来激活神经元 KCNQ 型 K+ 通道。

應用

瑞替加滨可用作参考标准品,用于通过高效液相色谱结合串联质谱和正离子大气压化学电离(HPLC-APCI-MS/MS)测定生物基质中的瑞替加滨。

生化/生理作用

瑞替加滨(依佐加滨)是一种具有抗惊厥活性的 Kv7.2-7.5 (KCNQ2-5)神经元钾通道开放剂。

象形圖

Skull and crossbonesEnvironment

訊號詞

Danger

危險聲明

危險分類

Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7. 2 (KCNQ2) channel by binding to its activation gate.
Wuttke VT, et al.
Molecular Pharmacology, 94, 71-76 (2005)
Determination of retigabine and its acetyl metabolite in biological matrices by on-line solid-phase extraction (column switching) liquid chromatography with tandem mass spectrometry.
Knebel GN, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 748(1), 97-111 (2000)
Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine.
Dousa M, et al.
Journal of Pharmaceutical and Biomedical Analysis, 94, 71-76 (2014)
Lyubov I Brueggemann et al.
Molecular pharmacology, 86(3), 330-341 (2014-06-20)
Recent research suggests that smooth muscle cells express Kv7.4 and Kv7.5 voltage-activated potassium channels, which contribute to maintenance of their resting membrane voltage. New pharmacologic activators of Kv7 channels, ML213 (N-mesitybicyclo[2.2.1]heptane-2-carboxamide) and ICA-069673 N-(6-chloropyridin-3-yl)-3,4-difluorobenzamide), have been reported to discriminate among

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门